The AJMC® COPD compendium is a comprehensive resource for clinical news and expert insights for chronic obstructive pulmonary disease.
May 20th 2024
Patients with chronic obstructive pulmonary disease (COPD) and/or preserved ratio impaired spirometry (PRISm) have an increased risk of all-cause and cause-specific mortality, highlighting the need for better understanding of these conditions through increased spirometry data collection.
Trial Shows Positive Long-term Safety Profile for Denervation Therapy in COPD
February 26th 2021Results from the AIRFLOW-1 study demonstrate that targeted lung denervation did not produce any severe adverse reactions in patients with chronic obstructive pulmonary disease (COPD) after 3 years.
Read More
Hospitalizations, ED Visits for COPD and Asthma Increase Under Certain Weather Conditions
February 20th 2021Changes in temperature and atmospheric pressure were found to be associated with higher rates of medical care utilization for patients with chronic obstructive pulmonary disease (COPD) and asthma.
Read More
Study Finds CV Risk Is Unknown for Many Patients With COPD
February 13th 2021A recent study found that the proportion of patients in the Netherlands with chronic obstructive pulmonary disease (COPD) who are being assessed for cardiovascular (CV) risk does not align with Dutch guideline recommendations.
Read More
Pulmonary Embolism Prevalence Appears Lower in Hospitalized Patients With COPD
February 11th 2021The prevalence of pulmonary embolism in certain hospitalized patients with chronic obstructive pulmonary disease (COPD) may be lower than previous research suggests, according to a recent study.
Read More
Inhaled Sugar Formulation May Reduce Ventilation Duration, Improve Lung Function in AECOPD
February 3rd 2021A pilot study among hospitalized patients on the use of an inhaled naturally occurring sugar showed several positive outcomes for those with acute exacerbations of chronic obstructive pulmonary disease (AECOPD).
Read More
Black Patients Hospitalized With COVID-19 Show High Incidence of Comorbidities, Mortality
January 23rd 2021Black patients hospitalized with coronavirus disease 2019 from an urban academic medical center in New York City exhibited high rates of comorbidities and in-hospital mortality, with chronic obstructive pulmonary disease and asthma significantly linked with early death.
Read More
Lymphocyte-HDL Ratio Outperforms Other Biomarkers for Predicting Pulmonary Function in COPD
January 17th 2021Investigators found that the ratio of lymphocytes to high-density lipoprotein (HDL) performed better in predicting pulmonary function than the neutrophil-lymphocyte ratio and the platelet-lymphocyte ratio.
Read More
Risk of Respiratory Complications, but Not Death, Is Higher for Patients With COPD Who Receive TAVI
January 14th 2021Study findings show that patients with chronic obstructive pulmonary disease (COPD) had increased risks of respiratory complications and pneumonia after undergoing a transcatheter aortic valve insertion (TAVI) compared with those without COPD.
Read More
How Lung Macrophages Develop May Have Role in Disease, Study Says
January 2nd 2021Usually, macrophages protect the lungs from attacks. But under certain conditions, lung macrophages can also contribute to severe lung diseases, like chronic obstructive pulmonary disease, or worsen coronavirus disease 2019 (COVID-19).
Read More
Study Finds Lack of Health Literacy Does Not Increase Mortality Risk in COPD
December 26th 2020A study from Denmark found that low health literacy was not a risk factor for mortality in patients with chronic obstructive pulmonary disease (COPD) compared with the general population and patients with other chronic conditions.
Read More
FDA Signs Off on EUA for Moderna's COVID-19 Vaccine
December 19th 2020The FDA Friday issued the second Emergency Use Authorization (EUA) for a coronavirus disease 2019 (COVID-19) vaccine, this one to Moderna, as the pandemic reached critical stress points across the country, especially in California.
Read More
Study Finds 3 Key Components That Could Make Pulmonary Rehabilitation More Effective for AECOPD
December 2nd 2020A review found that including exercise, breathing techniques, and education components in pulmonary rehabilitation for patients with acute exacerbations of chronic obstructive pulmonary disease (AECOPD) optimizes such programs.
Read More
HFNC May Improve AECOPD Prognosis Better Than Conventional Therapy
November 24th 2020A recent study found that high-flow nasal cannula may be a better option for first-line oxygen therapy for patients with chronic obstructive pulmonary disease with acute compensated hypercapnic respiratory failure than conventional therapy options.
Read More
Who Is More Likely to Receive Referrals for Pulmonary Rehabilitation for COPD?
November 18th 2020While patients with severe chronic obstructive pulmonary disease (COPD) are receiving referrals for pulmonary rehabilitation (PR), female patients and other groups are less likely to receive them.
Read More
Study Indicates ICS May Reduce New Cardiac Events in Patients With COPD
November 14th 2020A study looking at chronic obstructive pulmonary disease (COPD) and coronary heart disease found that inhaled corticosteroids (ICS) reduced future cardiac events in patients not known to have coronary heart disease.
Read More